I am a Senior Research Fellow in Translational Medicine, Quadram Institute (QI), Honorary Clinical Lecturer, School of Medicine, University of East Anglia, Norwich, UK and Clinical Director, Laboratory Medicine, Norfolk & Norwich University Hospital & Eastern Pathology Alliance Pathology Network, Norwich, UK
I hold the above positions as a clinical director, consultant clinical microbiologist and senior research fellow at QI. In my current role I lead a team of clinical, technician and administrative staff.
My main research interest is Clostridium difficile (renamed Clostridioides difficile).
In collaboration QI and NNUH gastroenterology dept. I have led the development of faecal microbiota transplantation service at NNUH since Aug. 2015. Collaborating with microbiology scientist colleagues in QI to investigate the use of whole genome sequencing directly on clinical samples. This will be very useful in identification and management of Campylobacter transmission / outbreaks.
Elumogo TN et al. S. Bordetella pertussis in a neonatal intensive care unit: identification of the mother as the likely source. Hosp Infect. 2012;82(2):133-5.
Brodbeck, A, Elumogo N, Rajendran, G. Evaluation of Procalcitonin at James Paget Intensive Care Unit, James Paget University Hospital NHS Foundation Trust, Anaesthesia and Intensive Care, Great Yarmouth. Critical Care. 2010;14(Suppl 1):P42 doi:10.1186/cc8274
… Elumogo N (corresponding, last author) Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review. Infect Dis Ther. 2018; 7:71–86.
…Elumogo N. et al. Microbial taxonomic and metabolic alterations during faecal microbiota transplantation to treat Clostridium difficile Journal of Infection. 2018; 77(2): 107-118.
….Elumogo N. et al. CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes. Genome Medicine. 2021; 13:21 https://doi.org/10.1186/s13073-021-00839-5